BridgeBio Pharma (BBIO) Debt to Equity (2018 - 2026)
BridgeBio Pharma recorded quarterly Debt to Equity of -$0.57 in Q1 2026, down 110.05% quarter-over-quarter from -$0.27 in Q4 2025.
BridgeBio Pharma's Debt to Equity history runs 9 years deep, the most recent figure standing at -$0.57 for Q1 2026.
- In Q1 2026, Debt to Equity changed N/A year-over-year to -$0.57; the TTM figure through Mar 2026 stood at -$0.57 (changed N/A YoY), while the FY2025 annual figure was -$0.27, up 27.65% from the prior year.
- Debt to Equity came in at -$0.57 for Q1 2026 at BridgeBio Pharma, down from -$0.27 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of -$0.27 in Q4 2025 to a low of -$0.57 in Q1 2026.
- A 5-year average of -$0.38 and a median of -$0.37 in 2024 frame the typical range for Debt to Equity.
- On a YoY basis, Debt to Equity climbed as much as 30.23% in 2022 and fell as far as 168.62% in 2022.
- BridgeBio Pharma's Debt to Equity stood at -$0.35 in 2022, then gained by 4.1% to -$0.33 in 2023, then slipped by 12.5% to -$0.37 in 2024, then increased by 27.65% to -$0.27 in 2025, then slumped by 110.05% to -$0.57 in 2026.
- According to Business Quant data, Debt to Equity over the past three periods registered -$0.57, -$0.27, and -$0.38 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 0.06 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | BridgeBio Pharma | 12.91 Bn | 11.98 Bn | 184.58 Mn | -0.57 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.57 |
| Dec 31, 2025 | -0.27 |
| Sep 30, 2025 | -0.38 |
| Dec 31, 2024 | -0.37 |
| Sep 30, 2024 | -0.36 |
| Jun 30, 2024 | -0.40 |
| Mar 31, 2024 | -0.42 |
| Dec 31, 2023 | -0.33 |
| Sep 30, 2023 | -0.37 |
| Jun 30, 2023 | -0.33 |
| Mar 31, 2023 | -0.36 |
| Dec 31, 2022 | -0.35 |
| Sep 30, 2022 | -0.37 |
| Jun 30, 2022 | -0.41 |
| Mar 31, 2022 | -0.42 |
| Dec 31, 2021 | -0.50 |
| Sep 30, 2021 | -0.14 |
| Jun 30, 2021 | -0.22 |
| Mar 31, 2021 | -0.24 |
| Dec 31, 2020 | 0.88 |
| Sep 30, 2020 | 0.43 |
| Jun 30, 2020 | 0.29 |
| Mar 31, 2020 | 0.21 |
| Dec 31, 2019 | 0.19 |
| Sep 30, 2019 | 0.14 |
| Jun 30, 2019 | 0.35 |
| Dec 31, 2018 | 0.14 |